The Boosting Potential of Bacteria in Cancer Immunotherapy

David C. Binder, Derek A. Wainwright*

*Corresponding author for this work

Research output: Contribution to journalShort surveypeer-review

10 Scopus citations


Salmonella Typhimurium, engineered to express flagellin B, recently demonstrated unprecedented tumor control through a TLR-dependent mechanism. Here, we review new observations that support the potential of utilizing modified bacteria to enhance antitumor immunity. We also discuss the implications of these findings for clinical applications, including immune checkpoint blockade therapies.

Original languageEnglish (US)
Pages (from-to)580-582
Number of pages3
JournalTrends in Molecular Medicine
Issue number7
StatePublished - Jul 2017

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology


Dive into the research topics of 'The Boosting Potential of Bacteria in Cancer Immunotherapy'. Together they form a unique fingerprint.

Cite this